NCT07157618 Prospective Pathology Foundation Models
| NCT ID | NCT07157618 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Nanfang Hospital, Southern Medical University |
| Condition | Pancancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2025-08-28 |
| Primary Completion | 2028-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,000 participants in total. It began in 2025-08-28 with a primary completion date of 2028-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Histopathology remains the gold standard for disease diagnosis, yet faces challenges including pathologist shortages and diagnostic model limitations. This underscores the critical need to develop deep learning-based pathology foundation models integrating prospective imaging and clinical data. Such models would enhance diagnostic accuracy and efficiency, enabling tumor grading, histo-molecular classification, and intelligent chemotherapy guidance - ultimately optimizing clinical workflows. However, a critical gap remains: the absence of prospectively validated, pan-disease pathology foundation models. Developing clinically validated models is therefore imperative.
Eligibility Criteria
Inclusion Criteria: 1. Aged 18-75 years old. 2. Patients with complete pathological slides and clinical information. Exclusion Criteria: 1.Patients with missing data or specimens not meeting quality control requirements for analysis.
Contact & Investigator
Li Liang
STUDY DIRECTOR
Nanfang Hospital, Southern Medical University
Frequently Asked Questions
Who can join the NCT07157618 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Pancancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07157618 currently recruiting?
Yes, NCT07157618 is actively recruiting participants. Contact the research team at zzyusmu@163.com for enrollment information.
Where is the NCT07157618 trial being conducted?
This trial is being conducted at Guangzhou, China, Jinan, China.
Who is sponsoring the NCT07157618 clinical trial?
NCT07157618 is sponsored by Nanfang Hospital, Southern Medical University. The principal investigator is Li Liang at Nanfang Hospital, Southern Medical University. The trial plans to enroll 2,000 participants.
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.